Home

  Substandard and falsified medical products

Substandard and falsified medical products are by their very nature difficult to detect. (...) Identifying a substandard or falsified medical product Some falsified medical products are almost visually identical to the genuine product and very difficult to detect. (...) Substandard and falsified medical products and the Internet Unregulated websites, social media platforms, and smartphone applications can also be direct conduits of substandard and falsified medical products.

Score: 874697.95 - https://www.who.int/news-room/...and-falsified-medical-products

  Medical Product Alert N°3/2020: Falsified medical products that claim to prevent, detect, treat or c

Medical Product Alert N°3/2020: Falsified medical products that claim to prevent, detect, treat or cure COVID-19 Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) End-buyers and consumers should be especially wary of such online scams and exert due-diligence when purchasing any medical product, whether online or not. WHO requests increased vigilance from national health authorities, healthcare professionals, members of the public and supply chain stakeholders worldwide to prevent the distribution of these falsified medical products. Increased vigilance should focus on hospitals, clinics, health centres, clinical laboratories, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from authentic and reliable sources.

Score: 860370.3 - https://www.who.int/news/item/...medical-product-alert-n-3-2020

  Medical Product Alert N° 11/2019 (English version)

Therefore, WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified medical products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products. (...) All medical products must be obtained from authentic and reliable sources. (...) National health authorities are asked to immediately notify WHO if these falsified medical products are discovered in their country.

Score: 859683.5 - https://www.who.int/news/item/...rt-n-11-2019-(english-version)

  2nd World Conference on Access to Medical Products: Achieving the SDGs 2030

Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / News / Detail / 2nd World Conference on Access to Medical Products: Achieving the SDGs 2030 2nd World Conference on Access to Medical Products: Achieving the SDGs 2030 10 October 2018 Highlights 9-11 October 2018, New Delhi To enable a holistic view on access to medical products, the Ministry of Health & Family Welfare (MoHFW), Government of India with the support of World Health Organization is organizing the ‘2nd World Conference on Access to Medical Products - Achieving the SDGs 2030’ at New Delhi from 9 -11 October 2018. (...) UHC includes appropriate access to affordable and quality-assured medical products supporting countries in achieving the targets of the health SDGs. India’s contribution towards access to medical products worldwide is well recognized. The main objective of the 2nd World Conference 2018 is to take forward the recommendations from the 1st World Conference 2017 and build on the work done for access to medical products in the context of SDGs, including trade agreements.

Score: 856859.9 - https://www.who.int/india/news...oducts-achieving-the-sdgs-2030

  Medical Product Alert N° 7/2019: Falsified meglumine antimoniate ampoules

Circulation of these falsified medical products is confirmed in the WHO Region of the Eastern Mediterranean. (...) Laboratory analysis of the product GLUCANTIME is pending This medical product alert N°7/2019 will subsequently be updated and posted on the WHO website once results are known. (...) All medical products must be obtained from authentic and reliable sources.

Score: 856352.7 - https://www.who.int/news/item/...ert-n-7-2019-(english-version)

  3 April 2020 Page: 1

Those subheadings could cover products that are for non-medical use. 2 2 PRODUCT SCOPE Medical products, in general, are widely spread in different Chapters of the Harmonized System (HS) classification. (...) Table 1: Top 10 importers of medical goods, 2019 Country Total imports Share of world medical imports (%) Share of total medical imports (%) Value ($ billion) Share of imports of all products (%) Medical equipment Medical supplies Medicines Personal protective products World 1,011.3 6 100 14 17 56 13 1. (...) Italy 37.1 8 4 9 15 66 9 10 Switzerland 36.9 13 4 6 9 80 5 Source: WTO Secretariat. Medical equipment 14% Medical supplies 17% Medicines 56% Personal protective products 13% 2019 Total Imports of Medical Products: $1.01 Trillion 4 Personal protective products represent 13% of medical imports The import value of personal protective products (hand soap and sanitizer, face masks, and protective spectacles) in 2019 was $135 billion.

Score: 855953.1 - https://www.wto.org/english/ne..._e/news20_e/rese_03apr20_e.pdf

  HIV POC Product profiles

Such products are considered as PPE rather than medical devices. (...) The product(s) shall conform to the relevant International Organisation for Standardisation (ISO) standards for suppliers/manufacturers of medical devices and risk management. c. (...) Copy in English. For products classified as medical devices, valid ISO 13485 certificate.

Score: 854569.2 - https://www.unicef.org/supply/...l-protective-equipment-PPE.pdf

  Medical Product Alert N°4/2020: Falsified Chloroquine (Update)

Please refer to   WHO medical product alert n°3/2020  for general information on falsified medical products in relation to the management  of COVID-19. WHO requests increased vigilance within the supply chains of countries likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from licensed, authentic and reliable sources.

Score: 854345.8 - https://www.who.int/news/item/...-medical-product-alert-n4-2020

  1 in 10 medical products in developing countries is substandard or falsified

Not only is this a waste of money for individuals and health systems that purchase these products, but substandard or falsified medical products can cause serious illness or even death. (...) WHO has received reports of substandard or falsified medical products ranging from cancer treatment to contraception. (...) These are especially popular in high-income countries, but more research is needed to determine the proportion and impact of sales of substandard or falsified medical products. Globalization is making it harder to regulate medical products.

Score: 853898.8 - https://www.who.int/news/item/...es-is-substandard-or-falsified

  Medical Product Alert N° 10/2019: Falsified Quinine Bisulphate and Quinine Sulphate

Please refer to the previous WHO Medical Product Alert N°2/2017 issued 27 July 2017. (...) All medical products must be obtained from authentic and reliable sources. (...) National health authorities are asked to immediately notify WHO if these falsified medical products are discovered in their country.

Score: 853464.8 - https://www.who.int/news/item/...rt-n-10-2019-(english-version)